SMTL ID : 7bu6.1

Structure of human beta1 adrenergic receptor bound to norepinephrine and nanobody 6B9

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

hetero-1-1-mer

Ligands

1 x GLC- GLC: alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose(Non-covalent)

GLC-GLC.1: 8 residues within 4Å: Chain A: L.14, E.18, I.36, G.37, D.77, A.80, A.81, F.111 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.77, A:A.81

1 x E5E: Noradrenaline(Non-covalent)

E5E.2: 10 residues within 4Å: Chain A: D.255, V.256, V.259, F.335, S.345, S.349, F.457, N.461, N.480, Y.484 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.256, A:V.256, A:V.259, A:F.335, A:F.457 Hydrogen bonds: A:D.255, A:S.345, A:S.345, A:S.349, A:N.461, A:N.480 pi-Stacking: A:F.458

7 x SO4: SULFATE ION(Non-functional Binders)

SO4.3: 6 residues within 4Å: Chain A: G.120, F.121, T.122, N.123, S.124, N.139 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:N.123, A:N.123, A:S.124, A:N.139 SO4.4: 3 residues within 4Å: Chain A: K.438, R.496, R.501 3 PLIP interactions: 3 interactions with chain A Salt bridges: A:K.438, A:R.496, A:R.501 SO4.5: 5 residues within 4Å: Chain A: T.149, P.150, N.151, R.152 Ligands: EPE.11 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.151, A:N.151, A:R.152 SO4.6: 2 residues within 4Å: Chain A: R.83, R.87 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.83, A:R.87 SO4.7: 2 residues within 4Å: Chain A: R.126, R.132 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.126, A:R.132 SO4.8: 3 residues within 4Å: Chain A: P.472, D.473, R.474 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:D.473, A:R.474 Salt bridges: A:R.474 SO4.9: 4 residues within 4Å: Chain A: A.318, E.319, N.338, R.339 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.319, A:R.339 Salt bridges: A:R.339

1 x NA: SODIUM ION(Non-functional Binders)

NA.10: 5 residues within 4Å: Chain A: C.326, Y.327, D.329, P.330, C.332 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Y.327, A:C.332

1 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)

EPE.11: 10 residues within 4Å: Chain A: I.16, D.17, R.155, S.171, W.174, V.237, W.238, G.239, R.240 Ligands: SO4.5 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.155, A:R.155

1 x 480: (2S)-2,3-dihydroxypropyl octanoate(Non-covalent)

480.12: 7 residues within 4Å: Chain A: M.178, I.185, V.236, R.474, V.477, F.478, W.481 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:I.185, A:F.478, A:F.478

1 x CLR: CHOLESTEROL(Non-covalent)

CLR.13: 4 residues within 4Å: Chain A: Y.351, V.462, F.466, H.467 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:Y.351, A:V.462, A:F.466

1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)

PG4.14: 5 residues within 4Å: Chain A: N.9, E.12, W.165, Y.168, A.169 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Xu, X. et al., Binding pathway determines norepinephrine selectivity for the human beta 1 AR over beta 2 AR. Cell Res. (2021)

Release Date

2020-12-02

Peptides

Endolysin,Endolysin,Endolysin,Beta-1 adrenergic receptor chimera: A
camelid antibody fragment: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Endolysin,Endolysin,Endolysin,Beta-1 adrenergic receptor chimera

camelid antibody fragment

Related Entries With Identical Sequence